Publications by authors named "Pascal Maisonobe"

Claim this Profile
L
Longitudinal Goal Attainment With Repeat Injections of AbobotulinumtoxinA in Adults With Lower Limb Spasticity: Results From a Prospective Observational Study.
Alberto Esquenazi, Richard D Zorowitz, Stephen Ashford, Mathieu Beneteau, Pascal Maisonobe

Arch Phys Med Rehabil· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Multicenter, Retrospective, Real-World Study of Treatment Outcomes Following on-label AbobotulinumtoxinA Injections for Adult Focal Spasticity in the United Kingdom.
Moheb Gaid, Caroline Brown, Mario Ippolito, Vadim Degtiar, Pascal Maisonobe

NeuroRehabilitation· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muscle selection and dosing in patients undergoing treatment with abobotulinumtoxinA for lower limb spasticity in real-world practice.
Richard D Zorowitz, Jorge Jacinto, Stephen Ashford, Mathieu Beneteau, Pascal Maisonobe

J Rehabil Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How many stroke survivors develop problematic spasticity requiring pharmacological therapy? An international (Europe and USA) observational study protocol.
Richard D Zorowitz, Laura Serrano Barrenechea, Simon Butet, Sergiu Groppa, David Hernández Herrero, Pascal Maisonobe

BMJ Open· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum Toxin Type A (BoNT-A) Use for Post-Stroke Spasticity: A Multicenter Study Using Natural Language Processing and Machine Learning.
María Jesús Antón, Montserrat Molina, José Gabriel Pérez, Santiago Pina, Noemí Tapiador, Pascal Maisonobe

Toxins (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum toxin A injection for post-stroke upper limb spasticity and rehabilitation practices from centers across Asian countries.
Raymond L Rosales, Nicholas V C Chia, Witsanu Kumthornthip, Khean Jin Goh, Choon Soon Mak, Pascal Maisonobe

Front Neurol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical presentation of patients with lower limb spasticity undergoing routine treatment with botulinum toxin: baseline findings from an international observational study.
Alberto Esquenazi, Richard D Zorowitz, Stephen Ashford, Pascal Maisonobe, Simon Page

J Rehabil Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity.
Clive Bezzina, Vadim Degtiar, Natalya Danchenko, Pascal Maisonobe, Benjamin Davis

Toxins (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post Hoc Subgroup Analysis of the BCause Study Assessing the Effect of AbobotulinumtoxinA on Post-Stroke Shoulder Pain in Adults.
Marcelo Riberto, João Amaury Frances, Regina Chueire, Ana Cristina Ferreira Garcia Amorim, Denise Xerez, Pascal Maisonobe

Toxins (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fertility of Women Treated during Childhood with Triptorelin (Depot Formulation) for Central Precocious Puberty: The PREFER Study.
Laetitia Martinerie, Jacques de Mouzon, Joelle Blumberg, Luigi di Nicola, Pascal Maisonobe

Horm Res Paediatr· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part I Development and responsiveness.
Lynne Turner-Stokes, Klemens Fheodoroff, Jorge Jacinto, Jeremy Lambert, Christine De La Loge, Pascal Maisonobe

J Rehabil Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Part II A first psychometric evaluation.
Lynne Turner-Stokes, Klemens Fheodoroff, Jorge Jacinto, Jeremy Lambert, Christine De La Loge, Pascal Maisonobe

J Rehabil Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment satisfaction in patients with cervical dystonia : Subgroup analysis of INTEREST-IN-CD-2].
Chi Wang Ip, Axel Schramm, Pascal Maisonobe, Emma Zaragatski, Thomas Sycha

Nervenarzt· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AbobotulinumtoxinA Versus OnabotulinumtoxinA in Adults with Upper Limb Spasticity: A Randomized, Double-Blind, Crossover Study Protocol.
Alberto Esquenazi, Ziyad Ayyoub, Monica Verduzco-Gutierrez, Pascal Maisonobe, James Otto

Adv Ther· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions.
Mark F Lew, Robert A Hauser, Stuart H Isaacson, Daniel Truong, Atul T Patel, Pascal Maisonobe

Clin Park Relat Disord· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.
Atul T Patel, Mark F Lew, Khashayar Dashtipour, Stuart Isaacson, Robert A Hauser, Pascal Maisonobe

PLoS One· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis.
Jean-Michel Gracies, Gerard E Francisco, Robert Jech, Svetlana Khatkova, Carl D Rios, Pascal Maisonobe

J Neurol Phys Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to AbobotulinumtoxinA injections in shoulder muscles to improve adult upper limb spasticity: Results from a phase 4 real-world study and a phase 3 open-label trial.
Thierry Lejeune, Svetlana Khatkova, Lynne Turner-Stokes, Philippe Picaut, Pascal Maisonobe

J Rehabil Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study.
Atul T Patel, Mark F Lew, Khashayar Dashtipour, Stuart Isaacson, Robert A Hauser, Pascal Maisonobe

PLoS One· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
Lynne Turner-Stokes, Jorge Jacinto, Klemens Fheodoroff, Allison Brashear, Pascal Maisonobe

J Rehabil Med· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and Analysis of the APPEAL Study.
Riekie Smit, Elena Gubanova, Joely Kaufman, Marina Landau, Beatriz Molina, Pascal Maisonobe

J Clin Aesthet Dermatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study.
Lynne Turner-Stokes, Jorge Jacinto, Klemens Fheodoroff, Allison Brashear, Pascal Maisonobe

J Rehabil Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effectiveness of Botulinum Toxin Type A (BoNT-A) Treatment in Brazilian Patients with Chronic Post-Stroke Spasticity: Results from the Observational, Multicenter, Prospective BCause Study.
Patricia Khan, Marcelo Riberto, João Amaury Frances, Regina Chueire, Ana Cristina Ferreira Garcia Amorim, Pascal Maisonobe

Toxins (Basel)· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AbobotulinumtoxinA using 2-mL dilution (500 U/2-mL) maintains durable improvement across multiple treatment cycles.
Khashayar Dashtipour, Stefan Wietek, Bruce Rubin, Pascal Maisonobe, Laxman Bahroo

J Clin Mov Disord· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of abobotulinumtoxinA on the clinical features of cervical dystonia in routine practice.
Richard M Trosch, Vijay P Misra, Pascal Maisonobe, Savary Om

Clin Park Relat Disord· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis